Loading clinical trials...
Loading clinical trials...
Fatigue is the most common symptom reported by 70 - 85 % of people with end-stage kidney disease (ESKD) receiving haemodialysis (HD). Educational interventions involving energy conservation strategies...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Queensland University of Technology
NCT07669519 · Fatigue, Colon Cancer
NCT07669168 · Health Services Accessibility, Rural Health, and more
NCT07659301 · Athletic Performance, Hyperbaric Oxygenation, and more
NCT07653074 · Myopia, Quality of Life
NCT06355050 · Prostate Cancer, Adaptive Radiotherapy, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions